Topical treatment effective for toenail fungal infection

April 12, 2013
Topical treatment effective for toenail fungal infection
Once daily topical efinaconazole is effective in treating fungal infections of the toenail, according to a study published in the April issue of the Journal of the American Academy of Dermatology.

(HealthDay)—Once daily topical efinaconazole is effective in treating fungal infections of the toenail, according to a study published in the April issue of the Journal of the American Academy of Dermatology.

As part of two studies, Boni E. Elewski, M.D., from the University of Alabama at Birmingham School of Medicine, and colleagues randomized 870 patients (first study) and 785 patients (second study) with toenail distal lateral subungual onychomycosis in a 3:1 ratio to efinaconazole (10 percent solution) or vehicle once a day for 48 weeks. Participants were followed up at four weeks post-treatment.

At week 52, the researchers found that the mycologic cure rate was significantly higher for patients treated with efinaconazole (55.2 versus 16.8 percent for study 1; 53.4 versus 16.9 percent for study 2). The complete cure rate (defined as no clinical involvement of the target toenail, negative examination, and negative fungal culture) was also significantly higher in the efinaconazole group (17.8 versus 3.3 percent for study 1; 15.2 versus 5.5 percent for study 2). (< 10 percent clinical involvement) was also achieved in significantly more patients treated with efinaconazole (35.7 versus 11.7 percent for study 1; 31.0 versus 11.9 percent for study 2). The rate of adverse events was similar for the efinaconazole and vehicle groups, according to the study.

"Once daily topical efinaconazole appears to be a viable alternative to oral treatment options for onychomycosis," Elewski and colleagues conclude.

The study was funded by Valeant Pharmaceuticals North America LLC, which manufactures efinaconazole. Several authors are employees of and/or disclosed with pharmaceutical companies, including Valeant.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Higher risk of VTE in CKD surgical patients on enoxaparin

June 8, 2012

(HealthDay) -- For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is significantly higher in those treated with enoxaparin compared to those ...

Hypertension ups retinopathy risk with HCV treatment

August 2, 2012

(HealthDay) -- For patients with hepatitis C virus (HCV) treated with pegylated interferon alpha (PegIFNα) and ribavirin, retinopathy occurs frequently, especially in those with hypertension, according to a study published ...

Vitreolytic ocriplasmin resolves vitreomacular traction

August 16, 2012

(HealthDay) -- Intravitreal injection of the vitreolytic agent ocriplasmin resolves vitreomacular traction and closes macular holes significantly better than placebo, but with a higher incidence of adverse events, according ...

Clopidogrel after MI less effective in diabetes patients

September 5, 2012

(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue of the Journal ...

Single topical ivermectin head lice treatment very effective

November 2, 2012

(HealthDay)—A single 10-minute, at-home treatment with topical ivermectin lotion eliminates head lice infestations in nearly all patients by the next day, according to a study published in the Nov. 1 issue of the New England ...

Restrictive transfusion strategy safe for acute GI bleeding

January 3, 2013

(HealthDay)—For patients with severe acute gastrointestinal bleeding, a restrictive transfusion approach is safe and effective compared with a liberal approach, according to a study published in the Jan. 2 issue of the ...

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

cyberCMDR
not rated yet Apr 12, 2013
Another effective treatment (in my experience). Shower everyday, but with this routine: First get yourself thoroughly wet by running the shower a minute or two. Next, apply some Selsun Blue shampoo to the affected area. Rinse your hands, then lather up the rest of your body with regular soap. Shampoo, with your hair still wet from the original wetting. Then turn the water back on to rinse your body and to clean your face. The period while lathering up allows the Selsun Blue to sink into the skin and nails. Keep this up, and the nails will grow out clean over a couple of months.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.